Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity.
about
Recent advances of vaccine adjuvants for infectious diseasesNasal vaccine innovation.Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Survey of human-use adjuvants.Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in miceCytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.The role of adjuvants in the development of mucosal vaccines.Molecular adjuvants and immunomodulators: new approaches to immunization.Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.Freeing vaccine adjuvants from dangerous immunological dogma
P2860
Q28083679-C7A3723C-D918-4F3C-8B2B-C7956F1B7FCDQ30395810-ABF951FE-CF21-4AD4-9054-98B33481D8D8Q33597356-0B568F45-D520-4C77-88E4-631ADEEB9660Q34309830-2A9DDCDE-656C-41E9-878A-75EA5FF83B91Q35192171-F7D89FCF-6816-4B13-A39E-16944BAA43F8Q35379258-C4D6FE78-E2D5-49C5-A813-992C36543AB0Q35433528-6208DD14-92AE-4093-BF49-5ABAE7E0F720Q35554157-01FBC6F3-80A2-42B0-B421-FD9FED686C00Q35953762-9A0CA262-040B-4540-B4BB-563FBCE42EADQ36194084-2CB43238-6F67-4EFD-9715-002A0D49A839Q36641572-37758795-2EE9-44E0-BF6F-F8B73EAE3EF1Q37812128-7C6D69F0-B66F-496C-8125-30F04E06F9E0Q39570111-BB176D47-59F8-4AD9-B149-FDD110CB852FQ42680550-F1C27ED5-76E4-4FC4-A607-1A9D78C7D08AQ57229596-ACDB7DD2-EF81-4562-9473-DF724054CE89
P2860
Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Bacterial cell wall products a ...... t enhance protective immunity.
@ast
Bacterial cell wall products a ...... t enhance protective immunity.
@en
type
label
Bacterial cell wall products a ...... t enhance protective immunity.
@ast
Bacterial cell wall products a ...... t enhance protective immunity.
@en
prefLabel
Bacterial cell wall products a ...... t enhance protective immunity.
@ast
Bacterial cell wall products a ...... t enhance protective immunity.
@en
P1476
Bacterial cell wall products a ...... t enhance protective immunity.
@en
P2093
G L Gustafson
M J Rhodes
P304
483-8; discussion 573-4
P356
10.1016/0923-2494(92)80058-S
P577
1992-06-01T00:00:00Z